Novo Nordisk | NVO - Loan Capital

Stock Price
47.64
Daily Change
4.32 9.97%
Monthly
-15.74%
Yearly
-44.86%
Q1 Forecast
56.42

Novo Nordisk reported DKK14.02B in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
ANI Pharmaceuticals USD 297.68M 310.67M Sep/2025
Aurora Cannabis CAD 34.99M 1.31M Sep/2025
Bausch Health Companies USD 20.46B 396M Sep/2025
Bristol-Myers Squibb USD 42.85B 1.62B Dec/2025
Canopy Growth CAD 226.33M 62.67M Sep/2025
Drreddys Laboratories INR 129.19M 1.84M Dec/2025
Eli Lilly USD 40.87B 6.69B Sep/2025
GlaxoSmithKline GBP 14.71B 186M Dec/2025
Merck USD 39.97B 6B Sep/2025
Novartis USD 24.24B 174M Sep/2025
Novo Nordisk DKK 118.94B 29.76B Dec/2025
Novo Nordisk DKK 14.02B 224.49M Sep/2025
Pacira USD 376.72M 1.37M Sep/2025
Perrigo USD 3.61B 7.4M Sep/2025
Prestige Brands USD 1.05B 39.73M Dec/2025
Sanofi EUR 15.72B 2.45B Dec/2025
Supernus Pharmaceuticals USD 400.38M 21.13M Mar/2022
Zoetis USD 7.07B 1.84B Sep/2025